Skip to main content

and
  1. No Access

    Chapter

    Multi-drug Resistant Tuberculosis in Travellers

    Tuberculosis remains a major global public health crisis, and multidrug-resistant tuberculosis (MDR-TB) has become a threat to disease control in many countries. More than 20% of humanity is latently infected ...

    Geraint Rhys Davies in Emerging and Re-emerging Infections in Travellers (2024)

  2. Article

    Open Access

    Quality of reporting of outcomes in phase III studies of pulmonary tuberculosis: a systematic review

    Despite more than 60 years of clinical trials, tuberculosis (TB) still causes a high global burden of mortality and morbidity. Treatment currently requires multiple drugs in combination, taken over a prolonged...

    Laura Jayne Bonnett, Gie Ken-Dror, Geraint Rhys Davies in Trials (2018)

  3. Article

    Open Access

    Quality of outcome reporting in phase II studies in pulmonary tuberculosis

    Tuberculosis (TB) remains a major killer amongst the infectious diseases. Current treatment involves a four-drug regimen for at least 6 months. New drugs and regimens are required to shorten treatment duration...

    Laura Jayne Bonnett, Geraint Rhys Davies in Trials (2015)